Publications
- Increasing the infliximab dose in rheumatoid arthritis patients: a randomised, double blind study failed to confirm its efficacy.2009 | First Faculty of Medicine
- Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis2008 | First Faculty of Medicine
- Magnetic Resonance in the Early Diagnostics of Rheumatodi Arthritis2006 | First Faculty of Medicine
- Early Diagnostic Methods for Rheumatoid Arthritis MRI in the Wrist Joint2006 | First Faculty of Medicine
- Increased expression of receptor activator of nuclear factor kappa B (RANK) and its ligand (RANKL) in rheumatoid arthritis synovial tissue2005 | First Faculty of Medicine
- Therapy of aktive rheumatoid arthritis by infiximab in combination with methotrexate - results of one zdar open study2004 | First Faculty of Medicine
- The Czech nationwide program for longitudinal monitoring of anti-TNF alpha therapy of rheumatoid arthritis - project ATTRA and its one-year experiencePublication without faculty affiliation
- The importance of cell surface RANKL in rheumatoid arthritis.Publication without faculty affiliation
- Infliximab in Treatment of Rheumatoid ArthritisPublication without faculty affiliation
- Raynaud's phenomenon as primary symptom of thyroid cancer +12021 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
Loading network view...